EVRYS BIO LLC
US UEI TM98GAF3Z6Q6 · SME
11public awards
$19.1Mtotal public funding
2026-08-04latest award
State aid awards (11)
| Date | Amount | Type | Programme | Granted by |
|---|---|---|---|---|
| 2026-08-04 | $6.9M | Grant | ALLERGY AND INFECTIOUS DISEASES RESEARCH | Department of Health and Human Services |
| 2024-07-18 | $2.0M | Grant | Development of a host-targeted antiviral as a chronic hepatitis B ther | Department of Health and Human Services |
| 2023-04-10 | $3.0M | Grant | A single antiviral to treat multiple opportunistic infections | Department of Health and Human Services |
| 2021-08-20 | $300k | Grant | Development of a host-targeted antiviral as a chronic hepatitis B ther | Department of Health and Human Services |
| 2019-08-01 | $3.9M | Grant | A single antiviral to treat multiple opportunistic infections | Department of Health and Human Services |
| 2018-09-25 | $150k | Grant | Host-Targeted Antiviral Drugs Providing Rapid, Scalable, Stable, Broad | Department of Defense |
| 2018-08-15 | $2.0M | Grant | SIRTUIN AGONISTS AS PAN INFLUENZA ANTIVIRALS | Department of Health and Human Services |
| 2016-08-08 | $305k | Grant | SIRTUIN AGONISTS AS PAN INFLUENZA ANTIVIRALS | Department of Health and Human Services |
| 2015-02-05 | $225k | Grant | An Antiviral to Treat Progressive Multifocal Leukoencephalopathy_(PML) | Department of Health and Human Services |
| 2014-01-01 | $225k | Grant | Host-Targeted Mechanism of Action for Treatment of Seasonal and Pandem | Department of Health and Human Services |
| 2014-01-01 | $225k | Grant | A Single Antiviral to Treat Multiple Opportunistic Infections | Department of Health and Human Services |
Want an alert when companies like this one get funded in your sector? Pro waitlist →